{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:58:42Z","timestamp":1768273122244,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03817-0","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T15:02:00Z","timestamp":1712329320000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-0972","authenticated-orcid":false,"given":"Matheo A. M.","family":"Stumpf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-6604","authenticated-orcid":false,"given":"Stefano A.","family":"Galliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-0441","authenticated-orcid":false,"given":"Cristina B. F.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8201-6756","authenticated-orcid":false,"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"3817_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","volume":"44","author":"A Glezer","year":"2015","unstructured":"A. Glezer, M.D. Bronstein, Prolactinomas. Endocrinol. Metab. Clin. North Am. 44, 71\u201378 (2015)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3817_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11102-019-01009-y","volume":"23","author":"H Duskin-Bitan","year":"2020","unstructured":"H. Duskin-Bitan, I. Shimon, Prolactinomas in males: any differences? Pituitary 23, 52\u201357 (2020)","journal-title":"Pituitary"},{"key":"3817_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000495184","volume":"109","author":"I Shimon","year":"2019","unstructured":"I. Shimon, Giant prolactinomas. Neuroendocrinology 109, 51\u201356 (2019)","journal-title":"Neuroendocrinology"},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms22010021","volume":"22","author":"V Ide","year":"2020","unstructured":"V. Ide, D. Vanderschueren, L. Antonio, Treatment of men with central hypogonadism: alternatives for testosterone replacement therapy. Int J. Mol. Sci. 22, 21 (2020)","journal-title":"Int J. Mol. Sci."},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"Petersenn","year":"2023","unstructured":"Petersenn, S. Fleseriu, M. Casanueva, F.F. Giustina, A. Biermasz, N. Biller BMK et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat. Rev. Endocrinol. 19, 722\u2013740 (2023)","journal-title":"Nat. Rev. Endocrinol."},{"key":"3817_CR6","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.21037\/tau.2019.11.16","volume":"9","author":"SC Krzastek","year":"2020","unstructured":"S.C. Krzastek, R.P. Smith, Non-testosterone management of male hypogonadism: an examination of the existing literature. Transl. Androl. Urol. 9, S160\u2013S170 (2020)","journal-title":"Transl. Androl. Urol."},{"key":"3817_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/andr.13146","volume":"10","author":"M Huijben","year":"2022","unstructured":"M. Huijben, M.T.W.T. Lock, V.F. de Kemp, L.M.O. de Kort, H.M.K. van Breda, Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. Andrology 10, 451\u2013469 (2022)","journal-title":"Andrology"},{"key":"3817_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1590\/s1677-5538.ibju.2021.0724","volume":"48","author":"CTD Ros","year":"2022","unstructured":"C.T.D. Ros, L.U.D. Ros, J.P.U.D. Ros, The role of clomiphene citrate in late onset male hypogonadism. Int. Braz. J. Urol. 48, 850\u2013856 (2022)","journal-title":"Int. Braz. J. Urol."},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/EJE-18-1000","volume":"181","author":"N Russell","year":"2019","unstructured":"N. Russell, M. Grossmann, MECHANISMS IN ENDOCRINOLOGY: estradiol as a male hormone. Eur. J. Endocrinol. 181, R23\u2013R43 (2019)","journal-title":"Eur. J. Endocrinol."},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-09-0084","volume":"161","author":"RS Ribeiro","year":"2009","unstructured":"R.S. Ribeiro, J. Abucham, Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment. Eur. J. Endocrinol. 161, 163\u2013169 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"3817_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2265.1989.tb03734.x","volume":"30","author":"TA Howlett","year":"1989","unstructured":"T.A. Howlett, J.A. Wass, A. Grossman, P.N. Plowman, M. Charlesworth, R. Touzel et al. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy. Clin. Endocrinol. 30, 131\u2013140 (1989)","journal-title":"Clin. Endocrinol."},{"key":"3817_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.aace.2021.01.004","volume":"7","author":"M Ali","year":"2021","unstructured":"M. Ali, L. Mirza, Morbid obesity due to prolactinoma and significant weight loss after dopamine agonist treatment. AACE Clin. Case Rep. 7, 204\u2013206 (2021)","journal-title":"AACE Clin. Case Rep."},{"key":"3817_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/JU.0000000000000396","volume":"202","author":"SC Krzastek","year":"2019","unstructured":"S.C. Krzastek, D. Sharma, N. Abdullah, M. Sultan, G.L. Machen, J.L. Wenzel et al. Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism. J. Urol. 202, 1029\u20131035 (2019)","journal-title":"J. Urol."},{"key":"3817_CR14","doi-asserted-by":"publisher","first-page":"A632","DOI":"10.1210\/jendso\/bvab048.1289","volume":"5","author":"M Voica","year":"2021","unstructured":"M. Voica, M. Tetlay, D.V. Thompson, F. Hasan, Recovery of male hypogonadism following successful treatment of prolactinoma: the experience of an integrated health network. J. Endocr. Soc. 5, A632\u2013A633 (2021)","journal-title":"J. Endocr. Soc."},{"key":"3817_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s11102-022-01242-y","volume":"25","author":"KM Al Dahmani","year":"2022","unstructured":"K.M. Al Dahmani, M.H. Almalki, A. Ekhzaimy, F. Aziz, A. Bashier, M.M. Mahzari et al. Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists. Pituitary 25, 658\u2013666 (2022)","journal-title":"Pituitary"},{"key":"3817_CR16","doi-asserted-by":"publisher","unstructured":"Z\u00fa\u00f1iga D., Stumpf M.A.M., Monteiro A.L.S., Glezer A. Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review. J Endocrinol Investig. (2023). https:\/\/doi.org\/10.1007\/s40618-023-02231-z.","DOI":"10.1007\/s40618-023-02231-z"},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11102-023-01305-8","volume":"26","author":"SA Urwyler","year":"2023","unstructured":"S.A. Urwyler, N. Karavitaki, Refractory lactotroph adenomas. Pituitary 26, 273\u2013277 (2023)","journal-title":"Pituitary"},{"key":"3817_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11102-019-00987-3","volume":"23","author":"P Souteiro","year":"2020","unstructured":"P. Souteiro, N. Karavitaki, Dopamine agonist resistant prolactinomas: any alternative medical treatment? Pituitary 23, 27\u201337 (2020)","journal-title":"Pituitary"},{"key":"3817_CR19","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.juro.2016.10.068","volume":"197","author":"KM Wheeler","year":"2017","unstructured":"K.M. Wheeler, R.P. Smith, R.A. Kumar, S. Setia, R.A. Costabile, P.K. Kavoussi, A comparison of secondary polycythemia in hypogonadal men treated with clomiphene citrate versus testosterone replacement: a multi-institutional study. J. Urol. 197, 1127\u20131131 (2017)","journal-title":"J. Urol."},{"key":"3817_CR20","first-page":"17","volume":"2017","author":"B Cangiano","year":"2017","unstructured":"B. Cangiano, C. Cacciatore, L. Persani, M. Bonomi, Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis. Endocrinol. Diabetes Metab. Case Rep. 2017, 17\u20130055 (2017)","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"3817_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s11102-022-01259-3","volume":"25","author":"Y Rudman","year":"2022","unstructured":"Y. Rudman, H. Duskin-Bitan, H. Masri-Iraqi, A. Akirov, I. Shimon, Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. Pituitary 25, 882\u2013890 (2022)","journal-title":"Pituitary"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03817-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:02:05Z","timestamp":1720861325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03817-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03817-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local Ethics Committees and all participants signed informed consent term.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}